Get 20M+ Full-Text Papers For Less Than $1.50/day. Subscribe now for You or Your Team.

Learn More →

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients... http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Lancet Oncology Pubmed

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

Safety and preliminary efficacy of venetoclax with decitabine or azacitidine in elderly patients with previously untreated acute myeloid leukaemia: a non-randomised, open-label, phase 1b study.

The Lancet Oncology , Volume 19 (2): 13 – Jan 25, 2019

Loading next page...
 
/lp/pubmed/safety-and-preliminary-efficacy-of-venetoclax-with-decitabine-or-vt5IsXEalS

References (26)

ISSN
1470-2045
DOI
10.1016/S1470-2045(18)30010-X
pmid
29339097

Abstract

Journal

The Lancet OncologyPubmed

Published: Jan 25, 2019

There are no references for this article.